Observational Study of caloric and nutrient intake, bone density , and body composition in infants and children with Spinal Muscular Atrophy
Poruk KE, Davis RH, Smart AL, Chisum BS, LaSalle BA, Chan GM, Gill G, Reyna SP, Swoboda KJ, Neuromuscul Disord, 1/1/2012De Novo mutations in ATPA3 cause alternating hemiplegia of Childhood
Heinzen EL, Swoboda KJ, Hitomi Y, Gurrieri F, Nicole S, de Vries B, Tiziano FD, Fontaine B, Walley MN Heavin S, Panagiotakaki E European Alternating Hemiplegia of Chil..., Nat Genet, 1/1/2012SMA CARNI-VAL Trial Part II: A Prospective, Single-Armed Trial of L-Carnitine and Valproic Acid in Ambulatory Children with Spinal Muscular Atrophy
Kissel JT, Scott C, Reyna SP, Crawford TO, Simard L, Krosschell K, Acsadi G, Elsheik B, Schroth M, D'Anjou D, LaSalle B, Prior T, Sorenson S, Maczulski J, Bromberg M, ..., PLoS ONE, 1/1/2011Reliability of the Modified Hammersmith Functional Motor Scale in Young Children with Spinal Muscular Atrophy
Krosschell KJ, Scott CB, Maczulski JA, Lewelt AJ, Reyna SP, Swoboda KJ, Muscle Nerve, 1/1/2011SMA CARNI-VAL trial part I: double-blind, randomized, placebo-controlled trial of L-carnitine and valproic acid in spinal muscular atrophy
Swoboda KJ, Scott CB, Crawford TO, Simard LR, Reyna SP, Krosschell KJ, Acsadi G, Elsheik B,
Schroth MK, D'Anjou G, LaSalle B, Prior TW, Sorenson SL, Maczulski JA, Br..., PLoS ONE, 1/1/2010Compound muscle action potential and motor function in children with spinal muscular atrophy
Lewelt A, Krosschell KJ, Scott C, Sakonju A, Kissel JT, Crawford TO, Acsadi G, D'anjou G, Elsheikh B, Reyna SP, Schroth MK, Maczulski JA, Stoddard GJ, Elovic E, Swobod..., Muscle Nerve, 1/1/2010Phase II open label study of valproic acid in spinal muscular atrophy
Swoboda KJ, Scott CB, Reyna SP, Prior TW, LaSalle B, Sorenson SL, Wood J, Acsadi G, Crawford TO, Kissel JT, Krosschell KJ, D'Anjou G, Bromberg MB, Schroth MK, Chan GM,..., PLoS ONE, 1/1/2009Alternating hemiplegia of childhood: early characteristics and evolution of a neurodevelopmental syndrome
Sweney MT, Silver K, Gerard-Blanluet M, Pedespan JM, Renault F, Arzimanoglou A, Schlesinger- Massart M, Lewelt AJ, Reyna SP, Swoboda KJ, Pediatrics, 1/1/2009Which features of the metabolic syndrome predict the prevalence and clinical outcomes of angiographic coronary artery disease?
Anderson JL, Horne BD, Jones HU, Reyna SP, Carlquist JF, Bair TL, Pearson RR, Lappe DL,
Muhlestein JB, Cardiology, 1/1/2007Homocysteine levels are associated with increased risk of
congestive heart failure in patients with and without coronary artery disease
May HT, Alharethi R, Anderson JL, Muhlestein JB, Reyna SP, Bair TL, Horne BD, Kfoury AG, Carlquist JF, Renlund DG, Cardiology, 1/1/2007Perspectives on clinical trials in spinal muscular atrophy [Review]
Swoboda KJ, Kissel JT, Crawford TO, Bromberg MB, Acsadi G, D'Anjou G, Krosschell KJ, Reyna SP, Schroth MK, Scott CB, Simard LR, J Child Neurol, 1/1/2007C-reactive protein predicts death in patients with non-ischemic cardiomyopathy
Ronnow BS, Reyna SP, Muhlestein JB, Horne BD, Allen Maycock CA, Bair TL, Carlquist JF,
Kfoury AG, Anderson JL, Renlund DG, Cardiology, 1/1/2005Sodium channel mutations and susceptibility to heart failure and atrial fibrillation
Olson TM, Michels VV, Ballew JD, Reyna SP, Karst ML, Herron KJ, Horton SC, Rodeheffer RJ, Anderson JL, JAMA, 1/1/2005Natural history of denervation in SMA: relation to age, SMN2 copy number, and function
Swoboda KJ, Prior TW, Scott CB, McNaught TP, Wride MC, Reyna SP, Bromberg MB, Ann Neurol, 1/1/2005Angiotensin converting enzyme inhibition reduces
elevated C-reactive protein in patients with angiographic coronary artery disease
Allen Maycock CA, Muhlestein JB, Horne BD, Pearson RR, Bair TL, Lim TH, Jones HU, Reyna SP, Moore SV, Renlund DG, Anderson JL, J Am Coll Cardiol, 1/1/2003Do statins provide clinical benefit in high-risk coronary artery disease patients with advanced left ventricular dysfunction?
eyna SP, Horne BD, Pearson RR, Bair TL, Allen Maycock CA, Rasmusson KD, Hall J, Moore SV, Anderson JL, Muhlestein JB, Renlund DG, J Am Coll Cardiol, 1/1/2003Does the -514T gene promoter variant of hepatic lipase predict increased HDL levels and reduced risk of angiographic coronary artery disease?
Whiting BM, Anderson JL, King CA, McKinney J, Muhlestein JB, Chaichana K, Bair TL, Reyna SP, Horne BD, Carlquist JF, J Am Coll Cardiol, 1/1/2003Is atrial fibrillation an inflammatory disease, reflected by elevated C-reactive protein?
Allen Maycock CA, Lappé DL, Crandall BG, Muhlestein JB, Horne BD, Bair TL, Li Q, Reyna SP, Renlund DG, Anderson JL, J Am Coll Cardiol, 1/1/2003Low socio-economic status is more predictive of increased hazard in women than men after angiographic diagnosis of coronary artery disease
Reyna SP, Muhlestein JB, Horne BD, Bair TL, Allen Maycock CA, Pearson RR, Moore SV, Renlund
DG, Anderson JL, J Am Coll Cardiol, 1/1/2003Which features of the metabolic syndrome predict clinical outcomes (death/myocardial infarction) in patients with angiographic coronary artery disease?
Jones HU, Muhlestein JB, Carlquist JF, Horne BD, Pearson RR, Allen Maycock CA, Reyna SP, Bair TL, Lappé DL, Renlund DG, Anderson JL, J Am Coll Cardiol, 1/1/2003Which lipid/lipoprotein ratio best predicts angiographic coronary artery disease?
Bair TL, Muhlestein JB, Carlquist JF, Allen Maycock CA, Pearson RR, Reyna SP, Horne BD, Anderson JL, J Am Coll Cardiol, 1/1/2003Genetic burden of polymorphisms related to lipid metabolism increases the risk of angiographic coronary artery disease
Horne BD, Anderson JL, Muhlestein JB, Renlund DG, Allen Maycock CA, Reyna SP, King CA, Whiting BM, Chaichana K, Carlquist JF, Circulation, 1/1/2002Heart failure teaching and monitoring interventions improve measures of clinical practice in the primary care setting
Crowell PS, Berg GL, Bateman K, Reyna SP, Allen Maycock CA, Hall J, Rasmusson K, Lappe' JM, Horne BD, Muhlestein JB, Anderson JL, Renlund DG, Circulation, 1/1/2002Lower residential economic status and insurance type independently predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary...
Horne BD, Muhlestein JB, Renlund DG, Bair TL, Reyna SP, Anderson JL, Circulation, 1/1/2002An institutional discharge medication program reduces future cardiovascular readmissions and mortality during the first year after coronary artery bypass graft surgery
Pearson RR, French TK, Horne BD, Roberts CA, Orton JA, Allen Maycock CA, Reyna SP, Wallace DS, Lappé DL, Anderson JL, Muhlestein JB, Circulation, 1/1/2001- Join now to see all
Universidad de San Carlos FOMSClass of 1987
New Data Revealed for Novartis SMA Gene TherapyMarch 7th, 2024
